0.709
price up icon1.29%   0.009
after-market Handel nachbörslich: .68 -0.029 -4.09%
loading

Evogene Ltd Aktie (EVGN) Neueste Nachrichten

pulisher
May 23, 2026

Evogene shares decline after revenue miss despite stronger-than-expected earnings (EVGN) - MSN

May 23, 2026
pulisher
May 22, 2026

Evogene Q1 2026 earnings preview - MSN

May 22, 2026
pulisher
May 21, 2026

Evogene Ltd. (NASDAQ:EVGN) Q1 2026 Earnings Call Transcript - Insider Monkey

May 21, 2026
pulisher
May 21, 2026

Evogene Reports First Quarter 2026 Financial Results - Dailyhunt

May 21, 2026
pulisher
May 21, 2026

Evogene Ltd stock (IL0010831684): Q1 revenue slump highlights high?risk transformation phase - AD HOC NEWS

May 21, 2026
pulisher
May 20, 2026

Evogene stock falls 5% on revenue miss despite earnings beat - Investing.com

May 20, 2026
pulisher
May 20, 2026

Evogene Earnings Call: AI Momentum vs. Cash Strain - TipRanks

May 20, 2026
pulisher
May 20, 2026

Evogene earnings beat by $0.26, revenue fell short of estimates - Investing.com Australia

May 20, 2026
pulisher
May 20, 2026

Evogene Q1 2026 Loss Deepens: -$0.60/Share vs -$0.28 Expected - AlphaStreet

May 20, 2026
pulisher
May 20, 2026

EVGN: Revenue fell sharply and net loss widened as focus shifted to core AI-driven pharma and ag chem - TradingView

May 20, 2026
pulisher
May 20, 2026

Earnings call transcript: Evogene reports Q1 2026 loss, stock rises 1.95% - Investing.com Australia

May 20, 2026
pulisher
May 20, 2026

EVGN: AI-driven pharma and ag chemical focus advances, but Q1 revenue drops and net loss widens - TradingView

May 20, 2026
pulisher
May 20, 2026

Evogene Ltd. Q1 2026 Earnings Call Summary - Yahoo Finance

May 20, 2026
pulisher
May 20, 2026

Evogene Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 20, 2026
pulisher
May 20, 2026

Evogene reports Q1 results: net loss widens amid revenue decline - grafa.com

May 20, 2026
pulisher
May 20, 2026

Evogene Shares Decline After Revenue Miss Despite Stronger-Than-Expected Earnings (EVGN) - Yahoo Finance

May 20, 2026
pulisher
May 20, 2026

Evogene Ltd reports results for the quarter ended March 31Earnings Summary - TradingView

May 20, 2026
pulisher
May 20, 2026

Evogene Ltd files for offering of 2.45 million ordinary shares by selling shareholder SEC filing - marketscreener.com

May 20, 2026
pulisher
May 20, 2026

Evogene 1Q Loss/Shr 60c >EVGN.TV - Moomoo

May 20, 2026
pulisher
May 20, 2026

Evogene Ltd Files For Offering Of 2.45 Million Ordinary Shares By Selling Shareholder SEC Filing - TradingView

May 20, 2026
pulisher
May 20, 2026

Evogene (NASDAQ: EVGN) registers 2.45M shares for resale, files Q1 2026 results - Stock Titan

May 20, 2026
pulisher
May 20, 2026

Evogene Tightens Focus on AI Small-Molecule Platform as Q1 2026 Revenue Falls - TipRanks

May 20, 2026
pulisher
May 20, 2026

Evogene : Q1 2026 Consolidated Financial Statements - marketscreener.com

May 20, 2026
pulisher
May 20, 2026

EVOGENE ($EVGN) Releases Q1 2026 Earnings - Quiver Quantitative

May 20, 2026
pulisher
May 20, 2026

Evogene stock falls 5% on revenue miss despite earnings beat By Investing.com - Investing.com Australia

May 20, 2026
pulisher
May 20, 2026

EVGN: Q1 2026 revenue declined and net loss widened, but AI-driven pipeline and partnerships advanced - TradingView

May 20, 2026
pulisher
May 20, 2026

Evogene: Q1 Earnings Snapshot - marketscreener.com

May 20, 2026
pulisher
May 20, 2026

Evogene (EVGN) Q1 2026 shows sharp revenue fall, wider loss and cash burn - Stock Titan

May 20, 2026
pulisher
May 20, 2026

Press Release: Evogene Reports First Quarter 2026 Financial Results - Moomoo

May 20, 2026
pulisher
May 20, 2026

Evogene Q1 2026 Earnings Call Transcript - MarketBeat

May 20, 2026
pulisher
May 19, 2026

EVGN Q1'26 Earnings: EPS estimate is (0.27) USD - TradingView

May 19, 2026
pulisher
May 18, 2026

Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short - TipRanks

May 18, 2026
pulisher
May 18, 2026

Evogene (EVGN) and Bayer terminate herbicide project, APTH1 assets return to AgPlenus - Stock Titan

May 18, 2026
pulisher
May 18, 2026

Evogene Ltd expected to post a loss of 27 cents a shareEarnings Preview - TradingView

May 18, 2026
pulisher
May 16, 2026

Evogene Ltd stock (IL0010831684): AI-driven biotech draws attention after recent financing update - AD HOC NEWS

May 16, 2026
pulisher
May 15, 2026

Evogene Ltd.Ordinary Shares (NQ: EVGN - The Chronicle-Journal

May 15, 2026
pulisher
May 15, 2026

Armistice Capital and Steven Boyd report 9.99% of EVGN (May 2026) - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Earnings Preview: Evogene to Report Financial Results Pre-market on May 20 - Moomoo

May 15, 2026
pulisher
May 15, 2026

Evogene (EVGN) Institutional Ownership 2026 - MarketBeat

May 15, 2026
pulisher
May 14, 2026

Evogene Ltd stock (IL0010831684): recent financing move and pipeline focus draw investor attention - AD HOC NEWS

May 14, 2026
pulisher
May 12, 2026

AI-designed drug molecules: Evogene presents GenAI model in Munich - Stock Titan

May 12, 2026
pulisher
May 12, 2026

Evogene to Present at the 24th Schrödinger European User Group Meeting - marketscreener.com

May 12, 2026
pulisher
May 11, 2026

TradingKey - TradingKey

May 11, 2026
pulisher
May 07, 2026

Evogene will discuss first-quarter results on a May 20 Zoom call - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Evogene Schedules First Quarter 2026 Financial Results Release - Barchart.com

May 07, 2026
pulisher
Apr 30, 2026

Genetically Modified Seeds Market 2026 Growth, Industry - openPR.com

Apr 30, 2026
pulisher
Apr 29, 2026

Evogene receives Nasdaq notification - MSN

Apr 29, 2026
pulisher
Apr 28, 2026

Evogene files for resale of 5.08M shares via warrant exercise - MSN

Apr 28, 2026
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
Kapitalisierung:     |  Volumen (24h):